Latest Treatment Advances in Bladder and Kidney Cancer

Share
Print

Tuesday, March 23, 2021  //  6:30-8:30 pm (EST)
Complimentary Live Virtual Program

Join Memorial Sloan Kettering (MSK) experts in the areas of bladder and kidney cancers for the Latest Treatment Advances in Bladder and Kidney Cancer, a complimentary CME event.

We will review the latest advances in robotic cystectomy and intracorporeal diversion for invasive bladder cancer. We will also explore the contemporary management of advanced kidney cancer and discuss genomic biomarkers in the treatment selection of advanced kidney cancer as well as a variety of other topics.

Audience

The intended audience for this program includes medical oncologists, urologists, internal and family medicine practitioners, and other affiliated healthcare professionals who are involved in the care of people with cancer or have a special interest in this area.

Accreditation

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement

Memorial Sloan Kettering Cancer Center designates this live activity for a maximum of 2.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Date & Time(s)

Location

This live virtual program will be delivered using Zoom. Detailed access instructions will be sent to all registered attendees prior to the start of the program.

Registration Details

Registration for this program is complimentary. Additional details and registration can be found online at mskcc.org/bladderkidneycancers.

Speaker(s)

Alvin Goh, MD
Associate Attending, Surgery
Advances in Robotic Cystectomy and Intracorporeal Diversion for Invasive Bladder Cancer

  • Understand the indications and selection criteria for minimally invasive cystectomy
  • Discuss methods to reduce complications and optimize recovery after surgery
  • Learn approaches to improve functional outcomes in urinary reconstruction

Abraham Hakimi, MD
Assistant Attending, Surgery
Contemporary Management of Advanced Kidney Cancer

  • Understand the role of surgery in advanced kidney cancer
  • Review updates on systemic therapy in kidney cancer
  • Discuss genomic biomarkers in treatment selection of advanced kidney cancer